Samsung introduces ‘Brain Health’ service to detect early signs of dementia

Samsung has announced that it will utilise data collected by its wearables and smartphones to help identify early signs of dementia. This feature will initially launch in beta in select markets and is designed to help families detect early signs of dementia.

Sandip Chakraborty

January 06, 2026 / 13:29 IST

Samsung

Samsung unveils 'Brain Health' to detect early signs of dementia via wearables
Feature uses Galaxy Watch and Ring data to track subtle behavior changes
'Brain Health' will launch in beta in select countries after clinical review

Did our AI summary help?

Samsung's next health feature could address and aim to prevent early signs of mental illness, such as dementia, with a new feature called ‘Brain Health.’ At CES 2026, the tech giant showcased this new feature, which will use data collected by Samsung wearables or smartphones. It’s an aggressive move to make a common wearable and a phone into a front-line screen for identifying potential dementia risk, a health problem avoided by most other consumer tech brands.

Samsung’s ‘Brain Health’ feature offers early dementia detection

During the company’s First Look event at CES 2026, Praveen Raja, the vice president and head of digital health at Samsung, stated that the tech firm is developing new tools to identify early signs of common mental illnesses, including dementia, by utilising data from its wearables and other connected devices. This would allow devices like the Galaxy Watch and the Galaxy Ring to monitor subtle changes in user behaviour.

Samsung has also clearly mentioned that the goal is not to diagnose users who are suffering from dementia or any other mental illness. Instead, these features will ensure that users and their families get to know about mental decline at the earliest stage, so that the necessary medical help is taken as soon as possible. The company also aims to offer more personalised exercise and sleep coaching based on data from connected devices, while providing suggestions for reducing the risk of common chronic diseases.

This innovative ‘Brain Health’ tool is currently undergoing clinical review by specialised institutions in both the company’s home country, South Korea, and other global regions. Although there is no information on when these ‘Brain Health’ features will be made available on a wider scale to all wearables and connected devices, the company has announced that they will initially be available in beta in select countries.